Q The idea of regulating the media is very much in the news. What are your views on the matter? A Obviously, the ideal way to do this would be self-regulation. I don’t think anyone in the profession has any doubt about that. Everybody agrees that self-regulation is a very good thing, but we don’t seem to move beyond that. And we are consequently opening a window for people who want...
More »SEARCH RESULT
Total Matching Records found : 4494
RTE Act can be a model for the world: Kapil Sibal
-The Times of India The RTE Act is an opportunity to break gender, caste, class and community barriers that threaten to damage the social fabric of our democracy and create fissures that could be ruinous to the country, writes Union HRD minister Kapil Sibal. The Supreme Court judgment upholding the constitutional validity of the Right of Children to Free and Compulsory Education (RTE) Act has once again focused public attention on education....
More »Bihar paradox: Phones outnumber toilets
-IANS Nearly 56 percent of families in Bihar have a mobile or landline connection, but about 77 percent of the population lack toilets, says a census report, highlighting the paradoxes in the state which has taken big leaps in development but also lagged behind in key areas. "Till 2001, only 2.2 percent families were using any kind of telecom facility in Bihar, now over half of its population owns a phone, as...
More »First Koodankulam reactor may be commissioned by June-P Sudhakar
Atomic Energy Regulatory Board's clearance being awaited Expressing satisfaction over the progress in preparing the first reactor of Kudankulam Nuclear Power Project for commissioning, Nuclear Power Corporation of India Limited (NPCIL) Chairman and Managing Director S.K. Jain has said the KKNPP was waiting for the Atomic Energy Regulatory Board's clearance for the opening of the reactor pressure vessel for inspecting the internal components' performance and subsequent loading of enriched uranium fuel...
More »A welcome first -TK Rajalakshmi
Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...
More »
